COMPANIES THAT MAKE COVID-19 VACCINES
1. Pfizer*/BioNTech SE*
Pfizer, as a company, states that “their purpose is grounded in our commitment to fund programs that provide public benefit, advance medical care and improve patient outcomes. Our belief is that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.
BioNTech SE, based in Germany, worked in collaboration with Pfizer to create one of the first COVID-19 vaccines granted EUA. They “aspire to utilize the full potential of the immune system to fight cancer and infectious diseases”.
Cooperatively, these two developed the ‘Pfizer’ Vaccine.
COVID-19 Vaccine Highlights
- Called: The vaccBNT162b2 or Comirnaty, AKA’ Pfizer.’
- Type of Vaccine: mRNA-based vaccine
- Reported general efficacy: 95%
- Administration: Given as 2 I.M. injections (IM/2)
- How stored: stored frozen @ -70
C; - EUA Granted 11 December, 20207
- Approved for use in 82 countries at the time of this report
2. Moderna, Inc.*
COVID-19 Vaccine Highlights
- Vaccine mRNA-1273,
- mRNA-based vaccine
- 1%
- IM/2
- @ -20 C;
- EUA Granted December 18, 2020 [18]
- Approved for use in 45 countries and 14 ongoing trials in 3 different countries
3. Janssen Pharmaceuticals, Inc.
Janssen Global Services, LLC is a pharmaceutical company of Johnson & Johnson Services, Inc. Janssen spends their attention concentrating on areas where they feel it can significantly impact. Areas such as immunology, vaccines, and infectious diseases, cancer research, and more are primary focuses.
Johnson & Johnson* totes itself as being the “world’s largest and most broadly based healthcare company.” They want to provide healthcare globally that is both affordable and reachable by all.
Jointly they developed:
COVID-19 Vaccine Highlights
- Janssen COVID-19 Vaccine aka JNJ-78436735 or Ad26.COV2.S
- Non-replicating viral vector
- 66%
- IM/1
- 2-8 C;
- EUA Granted 27 February, 202117(p1)
- At the initial start of writing, this vaccine was fully approved for use. However, as of April 20, 2021, the CDC28 has paused the use of the vaccine to investigate 6 or more cases of severe blood clots and low platelet levels. While currently under investigation in the U.S., they have decided to temporarily suspend its use. However, the European Union acknowledged the U.S.’s concerns but have not suspended use.
4. AstraZeneca*
COVID-19 Vaccine Highlights
- COVID-19 AstraZeneca aka ChAdOx1, nCoV-19, AzD1222, Vaxzeveria, or Covishield;
- Chimp adenovirus viral vector
- 4%
- IM/2
- 2-8 C;
- Currently in use in 65 countries with 24 ongoing trials in 15 different countries
- approved by WHO
5. Bharat Biotech
COVID-19 Vaccine Highlights
- Covaxin, BBV152;
- Whole-virus vero cell (inactivated vaccine);
- 81%;
- IM/2;
- 2-8oC;
- Currently being used in 6 countries with 5 clinical trials in 1 country
6. CanSino Biological Inc.
CanSinoBIO, in collaboration with the Beijing Institute of Biotechnology, developed the first novel Chinese-produced COVID-19 vaccine.34 A Chinese biopharmaceutical company, CanSinoBIO, works to achieve advances in healthcare with R&D, manufacturing advancements, and pioneering new vaccines for worldwide use.
COVID-19 Vaccine Highlights
- Convidicea, Ad5-nC0V
- Novel Recombinant, adenovirus type 5 vector (viral vector), genetically engineered
- IM/1 dose
- In use in 5 countries with 6 trials in 6 countries
7. Gamaleya National Center of Epidemiology and Microbiology
The Gamaleya National Center of Epidemiology and Microbiology, touted as one of the oldest research centers in Russia, founded in 1881, has developed Russia’s first COVID-19 Vaccine. The center has a special focus on infectious diseases both epidemiologically and creating various means to prevent illness or mitigate transmission and ill effects.
COVID-19 Vaccine Highlights
- Sputnik V, Gam-COVID-Vac, rAd26-S+rAd5-S
- Produced as a collaboration with Acellena Contract Drug Research and Development and the Health Ministry of the Russian Federation
- A non-replicating human recombinant adenovirus vector-based vaccine. It is unique from other viral vectors because it uses not one but two viral vectors as vehicles to transfer genetic material from a different virus into the human cell.37
- 91% efficacy
- IM/2 doses
- Approved for use in 60 countries with 19 trials in 6 countries
8. Federal Budgetary Research Institution State Research Center of Virology and Biotechnology AKA The Vector Institute
The Vector Institute represents a Russian government agency responsible for Russia’s second COVID-19 vaccine. It can be challenging to find information on this organization as the name varies depending on the reference. The center focuses on various means to address infectious diseases at all stages, from prevention to diagnosis.38 http://www.vector.nsc.ru/.
COVID-19 Vaccine Highlights
- EpiVacCorona Vaccine
- A peptide antigen vaccine
- Approved in 2 countries with 3 trials in 1 country
- https://www.precisionvaccinations.com/vaccines/epivaccorona-vaccine
9. Sinopharm
China National Pharmaceutical Group Co., Ltd., AKA Sinopharm, oversees a large healthcare conglomerate and includes 6 primary and over 1000 subsidiaries. Essentials for Sinopharm include R&D, drug development, and vaccine development. Reported to be the 6th largest vaccine manufacturer globally, they are a key provider for China’s National Vaccination Program. They are guided by the core value of “all for health, health for all.”
COVID-19 Vaccine Highlights
- BBIBP-CorV
- A Vero cell inactivated vaccine
- 3% efficacy
- IM/2
- 2-8oC
- Currently approved in 35 countries with 6 trials ongoing in 7 countries
10. Sinovac Biotech
Sinovac Biotech, Ltd., a Chinese company whose mission is to “supply vaccines to eliminate human diseases.” They focus on R&D through to commercialization of infectious disease vaccines, meeting needs that are unmet to date.
COVID-19 Vaccine Highlights
- CoronaVac
- Formalin-inactivated, adjuvanted with Alum (vero cell)
- 7%
- IM/2
- 2-8oC
- Approved for use in 20 countries with 15 ongoing trials in 7 countries
0 Comments